Clinical Trials Browser

Phase 1/2 × navitoclax × Lymphoid × Clear all

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05740449 2024-06-21

HEM-iSMART A

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00481091 2023-06-13

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase 1/2 Completed

60 enrolled 32 charts

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05054465 2021-09-23

ITALLI001

Phase 1/2 Not yet recruiting

48 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00406809 2021-08-02

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

Phase 1/2 Completed

81 enrolled

DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Sezary Syndrome, Leukemia, B-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

HEM-iSMART A

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

ITALLI001

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies